VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
b-blocker(Atenolol)
Preclinical
Small molecule
Y
Yonsei University
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Orthognathic Surgery
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Orthognathic Surgery
Preclinical
Completed
Clinical
Trials by Indication
[1]
Orthognathic Surgery
1 trial
The Effect of Antihypertensive Agents Concerning With Hemodynamics and Reduction of Anaesthetics in Orthognathic Surgery
Completed
·
Y
Yonsei University
·
N/A
·
NCT01839253
·
75 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for b-blocker(Atenolol). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
b-blocker(Atenolol) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for b-blocker(Atenolol). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Yonsei University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
Y
Yonsei University
Related News